Can-Fite BioPharma CANF
NYSE CANF
$1.85 -0.04 (-2.12%)
At close: Oct 22, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Change in Cash (2012 - 2013)

Updated

Can-Fite BioPharma's Change in Cash was $703,000 in FY2025, up 28.5% from $547,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Change in Cash (2012 - 2013) Analysis & Trends

From FY2015 onward, Can-Fite BioPharma has reported Change in Cash for 11 years.

  • Change in Cash shows a five-year compound annual growth rate of -33.9% (FY2020 to FY2025).
  • Annual Change in Cash has moved between -$3.88 million (FY2021) and $1.3 million (FY2023) over five years.
  • Per Business Quant data, Change in Cash in earlier years was $547,000 in FY2024 (-57.9%), $1.3 million in FY2023, -$1.41 million in FY2022 and -$3.88 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.67 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -3.51 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -2.82 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.49 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 739.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -2.64 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -4.45 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -727.00 Mn
10 Can-Fite BioPharma 2.42 Mn -17.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 4.11 Mn
Jun 30, 2012 -1.15 Mn
API Access

Can-Fite BioPharma Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=CANF&period=max&api_key=YOUR_API_KEY